Vascular Disease and Thrombosis

Loading the player...

TARDIS: Intensive Versus Guideline Antiplatelet Therapy

Kyra Becker, MD interviews Philip Bath, MD, primary investigator of the TARDIS trial about the results that he presented for ISC 2017.

Featured Science from Wednesday, Feb. 22

Main Event I: Opening Session
10:30 a.m. to 12:00 p.m. - Hall C

Head Position in Stroke Trial: An International Cluster Cross-over Randomized Trial
Craig S Anderson | George Institute of Global Health, Sydney NSW, Australia

RESULTS: Specific head positioning in acute stroke is of questionable value.


Aster Trial: Contact Aspiration versus Stent Retriever Front Line for Recanalisation in Acute Cerebral Infarction
Bertrand Lapergue | Foch Hospital and Versailles Saint Quentin en Yvelines University, Suresnes, France

RESULTS: Stent retriever and contact aspiration demonstrate similar safety and efficacy in acute cerebral infarction


Prospective, Multi-Center Study of Flow Diversion for Small and Medium-Sized Aneurysms: Results of the Premier Trial
Ricardo A Hanel | Baptist Neurological Institute, Jacksonville, FL

RESULTS: Flow diverter technology is safe and effective.

Featured Posters from Wednesday, Feb. 22

Late-Breaking Science Posters I
6:15 p.m. to 6:45 p.m. - Hall E

Association of Baseline ASPECTS and Collateral Score With Outcome Infarct Volume in Patients With Acute Ischemic Stroke due to Large Vessel Occlusions
Ivo G. Jansen | Academic Medical Center, Amsterdam, Netherlands

RESULTS: Baseline ASPECTS and collateral status predicted the infarct volume but did not modify the treatment effect.


Influence of Balloon, Conventional, or Distal Catheters on Angiographic and Clinical Outcomes in the STRATIS Registry
Osama O Zaidat | St. Vincent Mercy Medical Center, Toledo, OH


Primary Outcome Results of the Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke (STRATIS) Registry
Nils H Mueller-Kronast | Delray Medical Center/Tenet South Florida, Delray Beach, FL

Featured Science from Thursday, Feb. 23

Thursday Main Event
11:00 a.m. to 12:00 p.m. - Hall C

Intensive Versus Guideline Antiplatelet Therapy For Preventing Recurrence In Patients With Acute Ischaemic Stroke Or TIA: Main Results From The Triple Antiplatelets For Reducing Dependency In Ischaemic Stroke (TARDIS) Trial
Philip M Bath | University of Nottingham, Nottingham, United Kingdom

RESULTS: Neutral results: stroke recurrence was not lower; bleeding increased with intensive antiplatelet therapy.


Cilostazol Versus Aspirin in Ischemic Stroke Patients With Intracerebral Hemorrhage or Multiple Microbleeds
Sun U. Kwon Sr. | Asan Medical Center, Seoul, Republic of Korea

RESULTS: Stroke rates were less with cilostazol than aspirin, but more MI occurred with cilostazol.


Resumption of Oral Anticoagulation After Intracerebral Hemorrhage is Associated With Decreased Mortality and Favorable Functional Outcome
Alessandro Biffi | Massachusetts General Hospital, Boston, MA

RESULTS: The favorable findings in both non-lobar and lobar ICH indicate a need for more randomized clinical trials.


Efficacy and Safety of Nimodipine in Vascular Mild Cognitive Impairment: A Randomized Placebo Controlled Trial
Huaguang Zheng | Capital Medical University, Beijing Tiantan Hospital, Beijing, China

RESULTS: Nimodipine was no better than placebo in preventing cognitive decline.



 

Second Generation Hydrogel-coated Coils for the Endovascular Treatment of Intracranial Aneurysms: Final Results of a Randomized Controlled Trial
Christian Taschner | University Hospital Freiburg, Freiburg, Germany

RESULTS: Compared to standard platinum coils, there were fewer adverse events at 18 months with the hydrogel-coated coils.

Late-Breaking Science Oral Abstracts I
1:30 p.m. to 3:00 p.m. - Grand Ballroom B

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack of Atherosclerotic Origin
Pierre Amarenco | Paris Diderot University, Paris, France

RESULTS: At 90 days, ticagrelor prevented more strokes, MIs, and deaths than aspirin in patients with acute stroke or transient ischemic attack of atherosclerotic origin.


E-cigarette Exposure Alters Brain Glucose Utilization and Stroke Outcome
Ali E. Sifat |Texas Tech University Health Science Center School of Pharmacy, Amarillo, TX

RESULTS: Vaping is not safer than smoking; stroke risk may be similar if not higher.


Safety and Feasibility of Combination of Ticagrelor and Aspirin in Patients With Minor Stroke or TIA :Interim Analyses of the Platelet Reactivity in Acute Stroke or Transient Ischemic Attack (PRINCE) Trial
Yilong Wang | Capital Medical University, Beijing Tiantan Hospital, Beijing, China

RESULTS: Adverse events led to more medication discontinuation in the ticagrelor arm compared to the clopidogrel arm.


Rapid Increase in Endovascular Thrombectomy for Acute Ischemic Stroke in the United States: Data From Get With the Guidelines-Stroke
Eric E Smith | University of Calgary, Calgary, AB, Canada

RESULTS: Randomized controlled trial results and updated guidelines prompted more use of endovascular thrombectomy.


Interhospital Transfer Prior to Thrombectomy is Associated With Delayed Treatment and Worse Outcome in the STRATIS Registry
Michael T Froehler | Vanderbilt University, Nashville, TN

RESULTS: Strategies to spot large vessel occlusion and use endovascular-capable centers may improve outcomes.

Featured Science from Friday, Feb. 24

Closing Main Event
10:30 a.m. to 12:30 p.m. - Hall C

Randomized Trial of Hemostatic Therapy for 'Spot Sign' Positive Intracerebral Hemorrhage: Primary Results From the SPOTLIGHT/STOP-IT Study Collaboration
David J. Gladstone | University of Toronto, Toronto, ON, Canada

RESULTS: Emergency CT angiography has prognostic value in acute intracerebral hemorrhage, but treatment with rFVIIa did not improve outcomes.


Randomized Controlled Trial of Early versus Delayed Statin Therapy in Patients With Acute Ischemic Stroke
Shinichi Yoshimura | Hyogo College of Medicine, Nisinomiya City, Japan

RESULTS: Stroke disability was not reduced with early statin treatment for acute ischemic stroke.

Scientific Sessions 2017

Scientific Sessions: Nov. 11-15
Exhibits: Nov. 12-14
ReSuscitation Science Symposium: Nov. 11-12
Cardiovascular and Stroke Nursing Symposium: Nov. 14-15

Anaheim, California
 

Learn about Scientific Sessions 2017

Professional Online Network

Related Councils

Council on Peripheral Vascular Disease (PVD)

Council on Peripheral Vascular Disease (PVD)

The Council on Peripheral Vascular Disease (PVD) seeks to integrate the academic and clinical missions of all interdisciplinary vascular health professionals in order to expand professional and public vascular education; to advance the basic science and clinical research and evidence based practice; and to thereby improve clinical outcomes of individuals with PVD.

Joshua A. Beckman, MD, MS, FAHA
Chair, Council on Peripheral Vascular Disease

ATVB|PVD Scientific Sessions       Circulation       PVD Council Awards

Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)

Steven R. Lentz, MD, PhD, FAHA

The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.

Steven R. Lentz, MD, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology

ATVB|PVD Scientific Sessions       Arteriosclerosis, Thrombosis, and Vascular Biology       ATVB Council Awards

Council on Clinical Cardiology (CLCD)

Ileana L. Piña, MD, MPH, FAHA, FACC

The purpose of the Council on Clinical Cardiology (CLCD) is to achieve the objectives of the American Heart Association (AHA) in the field of clinical cardiology, to promote excellence in clinical care and to foster the professional development and education of clinical cardiologists. Through council-sponsored symposia, panels and scientific conferences, members can access new developments in the field and interpret and promote clinical cardiology to professional and lay audiences.

Ileana L. Piña, MD, MPH, FAHA, FACC
Chair, Council on Clinical Cardiology

Scientific Sessions       Circulation       CLCD Council Awards

Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (3CPR)

Benjamin S. Abella, MD, MPhil, FAHA

The American Heart Association's (AHA) strategic goal to reduce coronary heart disease, stroke and risk by 20 percent by the year 2020 has led to an emphasis on the importance of resuscitation and the chain of survival in AHA activities and use of resources. The Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (3CPR) bench-to-bedside and community approach ranges from integrated cardiopulmonary physiology to issues of critical care, emergency cardiovascular care and CPR. Pulmonary hypertension and regulation of the pulmonary circulation have historically been areas of investigation for many of our council members. The council is keenly interested in promoting approaches that include clinical care, clinical research and basic science.

Council activities focus on developing research interests and careers of young investigators, writing scientific statements for the AHA, supporting scientific meetings and providing representation on various American Heart Association committees.

Benjamin S. Abella, MD, MPhil, FAHA
Chair, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation

Scientific Sessions       Circulation       3CPR Council Awards